Total Payments
$59,756
2023 Payments
$170.47
Companies
8
Transactions
50
Medicare Patients
790
Medicare Billing
$337,005
Payment Breakdown by Category
Other$51,160 (85.6%)
Travel$3,794 (6.3%)
Consulting$2,550 (4.3%)
Food & Beverage$2,252 (3.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $42,340 | 13 | 70.9% |
| Honoraria | $8,820 | 1 | 14.8% |
| Travel and Lodging | $3,794 | 13 | 6.3% |
| Consulting Fee | $2,550 | 1 | 4.3% |
| Food and Beverage | $2,252 | 22 | 3.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| La Jolla Pharmaceutical Company | $55,310 | 35 | $0 (2018) |
| Alexion Pharmaceuticals, Inc. | $3,822 | 8 | $0 (2017) |
| Inari Medical, Inc. | $170.47 | 1 | $0 (2023) |
| Shionogi Inc | $123.13 | 1 | $0 (2022) |
| Mallinckrodt LLC | $113.92 | 1 | $0 (2017) |
| NxStage Medical, Inc. | $102.58 | 2 | $0 (2019) |
| Collegium Pharmaceutical, Inc. | $96.04 | 1 | $0 (2017) |
| Merck Sharp & Dohme Corporation | $17.64 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $170.47 | 1 | Inari Medical, Inc. ($170.47) |
| 2022 | $123.13 | 1 | Shionogi Inc ($123.13) |
| 2019 | $120.22 | 3 | NxStage Medical, Inc. ($102.58) |
| 2018 | $55,310 | 35 | La Jolla Pharmaceutical Company ($55,310) |
| 2017 | $4,032 | 10 | Alexion Pharmaceuticals, Inc. ($3,822) |
All Payment Transactions
50 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/07/2023 | Inari Medical, Inc. | FLOWTRIEVER CATHETER, S (Device), CT THROMBECTOMY SYSTEM KIT | Food and Beverage | In-kind items and services | $170.47 | General |
| Category: VTE | ||||||
| 10/13/2022 | Shionogi Inc | Fetroja (Drug) | Food and Beverage | In-kind items and services | $123.13 | General |
| Category: Infections and Infectious Diseases | ||||||
| 03/04/2019 | Merck Sharp & Dohme Corporation | BRIDION (Drug), ENTEREG | Food and Beverage | In-kind items and services | $17.64 | General |
| Category: NEUROSCIENCE | ||||||
| 01/30/2019 | NxStage Medical, Inc. | SYSTEM ONE (Device) | Food and Beverage | In-kind items and services | $14.81 | General |
| Category: Nephrology | ||||||
| 01/29/2019 | NxStage Medical, Inc. | SYSTEM ONE (Device) | Food and Beverage | In-kind items and services | $87.77 | General |
| Category: Nephrology | ||||||
| 12/18/2018 | La Jolla Pharmaceutical Company | GIAPREZA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,900.00 | General |
| Category: GIAPREZA | ||||||
| 12/18/2018 | La Jolla Pharmaceutical Company | GIAPREZA (Drug) | Travel and Lodging | In-kind items and services | $484.48 | General |
| Category: GIAPREZA | ||||||
| 12/18/2018 | La Jolla Pharmaceutical Company | GIAPREZA (Drug) | Food and Beverage | In-kind items and services | $122.67 | General |
| Category: GIAPREZA | ||||||
| 12/17/2018 | La Jolla Pharmaceutical Company | GIAPREZA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,430.00 | General |
| Category: GIAPREZA | ||||||
| 12/17/2018 | La Jolla Pharmaceutical Company | GIAPREZA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,940.00 | General |
| Category: GIAPREZA | ||||||
| 12/17/2018 | La Jolla Pharmaceutical Company | GIAPREZA (Drug) | Travel and Lodging | In-kind items and services | $959.32 | General |
| Category: GIAPREZA | ||||||
| 12/17/2018 | La Jolla Pharmaceutical Company | GIAPREZA (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: GIAPREZA | ||||||
| 12/12/2018 | La Jolla Pharmaceutical Company | GIAPREZA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,920.00 | General |
| Category: GIAPREZA | ||||||
| 12/12/2018 | La Jolla Pharmaceutical Company | GIAPREZA (Drug) | Travel and Lodging | In-kind items and services | $527.54 | General |
| Category: GIAPREZA | ||||||
| 12/12/2018 | La Jolla Pharmaceutical Company | GIAPREZA (Drug) | Food and Beverage | In-kind items and services | $90.57 | General |
| Category: GIAPREZA | ||||||
| 12/11/2018 | La Jolla Pharmaceutical Company | GIAPREZA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,920.00 | General |
| Category: GIAPREZA | ||||||
| 12/11/2018 | La Jolla Pharmaceutical Company | GIAPREZA (Drug) | Food and Beverage | In-kind items and services | $118.56 | General |
| Category: GIAPREZA | ||||||
| 12/05/2018 | La Jolla Pharmaceutical Company | GIAPREZA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,940.00 | General |
| Category: GIAPREZA | ||||||
| 12/05/2018 | La Jolla Pharmaceutical Company | GIAPREZA (Drug) | Travel and Lodging | In-kind items and services | $128.62 | General |
| Category: GIAPREZA | ||||||
| 12/05/2018 | La Jolla Pharmaceutical Company | GIAPREZA (Drug) | Food and Beverage | In-kind items and services | $86.04 | General |
| Category: GIAPREZA | ||||||
| 10/07/2018 | La Jolla Pharmaceutical Company | GIAPREZA (Drug) | Honoraria | Cash or cash equivalent | $8,820.00 | General |
| Category: GIAPREZA | ||||||
| 10/07/2018 | La Jolla Pharmaceutical Company | GIAPREZA (Drug) | Food and Beverage | In-kind items and services | $159.19 | General |
| Category: GIAPREZA | ||||||
| 09/26/2018 | La Jolla Pharmaceutical Company | GIAPREZA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $490.00 | General |
| Category: GIAPREZA | ||||||
| 07/19/2018 | La Jolla Pharmaceutical Company | GIAPREZA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,920.00 | General |
| Category: GIAPREZA | ||||||
| 07/19/2018 | La Jolla Pharmaceutical Company | GIAPREZA (Drug) | Travel and Lodging | In-kind items and services | $434.16 | General |
| Category: GIAPREZA | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 128 | 313 | $182,479 | $58,442 |
| 2022 | 1 | 193 | 451 | $262,933 | $86,432 |
| 2021 | 3 | 194 | 470 | $257,043 | $90,028 |
| 2020 | 4 | 275 | 550 | $280,725 | $102,103 |
Total Patients
790
Total Services
1,784
Medicare Billing
$337,005
Procedure Codes
9
All Medicare Procedures & Services
9 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 128 | 313 | $182,479 | $58,442 | 32.0% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 193 | 451 | $262,933 | $86,432 | 32.9% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 170 | 446 | $245,511 | $88,613 | 36.1% |
| 36556 | Insertion of central venous catheter for infusion, patient 5 years or older, not tunneled | Facility | 2021 | 12 | 12 | $8,400 | $932.04 | 11.1% |
| 36620 | Insertion of arterial catheter for blood sampling or infusion, accessed through the skin | Facility | 2021 | 12 | 12 | $3,132 | $483.24 | 15.4% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2020 | 215 | 485 | $250,260 | $97,172 | 38.8% |
| 36556 | Insertion of central venous catheter for infusion, patient 5 years or older | Facility | 2020 | 22 | 26 | $18,200 | $2,055 | 11.3% |
| 31500 | Emergent insertion of breathing tube into windpipe cartilage using an endoscope | Facility | 2020 | 14 | 14 | $5,740 | $1,859 | 32.4% |
| 36620 | Insertion of arterial catheter for blood sampling or infusion, accessed through the skin | Facility | 2020 | 24 | 25 | $6,525 | $1,017 | 15.6% |
About Dr. Michael Seneff, MD
Dr. Michael Seneff, MD is a Internal Medicine healthcare provider based in Washington, District of Columbia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/14/2006. The National Provider Identifier (NPI) number assigned to this provider is 1740259860.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Seneff, MD has received a total of $59,756 in payments from pharmaceutical and medical device companies, with $170.47 received in 2023. These payments were reported across 50 transactions from 8 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($42,340).
As a Medicare-enrolled provider, Seneff has provided services to 790 Medicare beneficiaries, totaling 1,784 services with total Medicare billing of $337,005. Data is available for 4 years (2020–2023), covering 9 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Critical Care Medicine
- Location Washington, DC
- Active Since 03/14/2006
- Last Updated 09/11/2025
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1740259860
Products in Payments
- GIAPREZA (Drug) $55,310
- SOLIRIS (Drug) $3,822
- FLOWTRIEVER CATHETER, S (Device) $170.47
- Fetroja (Drug) $123.13
- OFIRMEV (Drug) $113.92
- SYSTEM ONE (Device) $102.58
- Xtampza ER (Drug) $96.04
- BRIDION (Drug) $17.64
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Washington
Lawrence Dubuske, M.d, M.D
Internal Medicine — Payments: $1.8M
Internal Medicine $1.8M
Kavita Patel, M.d, M.D
Internal Medicine — Payments: $1.6M
Internal Medicine $1.6M
Andrea Singer
Internal Medicine — Payments: $1.1M
Internal Medicine $1.1M
Dr. Theo Hodge, Md, MD
Internal Medicine — Payments: $1.1M
Internal Medicine $1.1M
Ashte Collins, M.d, M.D
Internal Medicine — Payments: $837,513
Internal Medicine $837,513
Manish Shah, Md, MD
Internal Medicine — Payments: $456,731
Internal Medicine $456,731